 |
市場調査レポート
商品コード
1373818
腎デナベーションの世界市場 (2023-2030年)：タイプ (カテーテル・RFジェネレーター)・技術 (高周波・超音波) 別の規模・シェア・成長分析・予測Global Renal Denervation Market Size, Share, Growth Analysis, By Type(Catheters, RF generators), By Technology(Radiofrequency, ultrasound) - Industry Forecast 2023-2030 |
||||||
| 腎デナベーションの世界市場 (2023-2030年)：タイプ (カテーテル・RFジェネレーター)・技術 (高周波・超音波) 別の規模・シェア・成長分析・予測 |
|
出版日: 2023年10月06日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の腎デナベーションの市場規模は、2021年の2億1,949万米ドル、2022年の3億882万米ドルから、予測期間中は40.7%のCAGRで推移し、2030年には10億7,477万米ドルの規模に成長すると予測されています。
世界の腎デナベーションの市場は近年著しい成長を遂げており、今後も上昇基調を維持する見通しです。腎デナベーション市場の成長の原動力となっているのは、世界規模での高血圧の有病率の増加と、腎デナベーションのメリットに対する認知度の拡大です。高血圧に関連する健康上の懸念が拡大していることから、腎デナベーションなどの効果的な代替治療に対する需要が高まっています。その他の利点として、薬物治療への依存度の低減や、患者の予後改善などがあり、医療従事者や患者による採用が進んでいます。さらに、医療機器の技術的進歩も市場成長を促進する上で重要な役割を果たしています。腎デナベーション処置には現在、腎神経を選択的にアブレーションするための高周波または超音波エネルギーを備えた革新的なカテーテルシステムが組み込まれています。このような技術的強化により、処置の精度と安全性が高まり、その採用がさらに促進されています。
しかし一方で、腎デナベーション市場にはいくつかの課題も残されています。主な障壁としては、この処置の持続的有効性と安全性を確認する長期臨床データがないことがあります。初期の研究では有望な結果が示されていますが、腎デナベーションを高血圧の標準的な治療法として確立するには、さらなるエビデンスが必要です。
当レポートでは、世界の腎デナベーションの市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。
目次
- エグゼクティブサマリー
- 調査手法
- 親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 主要な市場洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資分析
- 主要な成功要因
- 競合の程度
- 市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 市場力学
- 規制状況
- ポーターの分析
- 将来のディスラプションに関するSkyquestの特別な洞察
- 世界の腎デナベーション市場：タイプ別
- 市場概要
- カテーテル
- RFジェネレーター
- 神経修飾剤
- 世界の腎デナベーション市場：技術別
- 市場概要
- 高周波
- 超音波
- マイクロインフュージョン
- 世界の腎デナベーション市場：地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
- 競合情勢
- トップ5社の比較
- 主要企業の市場での位置付け
- 主要企業の採用戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア
- 主要企業プロファイル
- Medtronic
- Boston Scientific Corporation
- ReCor Medical
- Ablative Solutions
- Mercator MedSystems
- Terumo Corporation
- St. Jude Medical (Abbott Laboratories)
- CardioSonic
- Symple Surgical
- Soundbite Medical Solutions
- Vessix Vascular (Boston Scientific)
- Renal Dynamics (Boston Scientific)
- Kona Medical
- Ablacon
- Cardiosonic Ltd.
- EndoCross Ltd.
- Caldus Medical
- OxSonics
- Nexeon MedSystems
- Johnson & Johnson
Global Renal Denervation Market size was valued at USD 219.49 million in 2021 and is poised to grow from USD 308.82 million in 2022 to USD 1,074.77 million by 2030, at a CAGR of 40.7% during the forecast period (2023-2030).
The global market for renal denervation has experienced significant growth in recent years and is poised to maintain its upward trajectory. Renal denervation is a minimally invasive medical procedure employed to manage hypertension, targeting the renal nerves responsible for regulating blood pressure. The market's expansion is driven by the increasing prevalence of hypertension on a global scale and a growing awareness of the advantages associated with renal denervation. A key driving force behind the renal denervation market is the rising incidence of hypertension, a major contributor to cardiovascular diseases. Given the ongoing global health concern surrounding hypertension, there is a mounting demand for effective treatment alternatives like renal denervation. Additionally, the procedure offers numerous benefits, including reduced reliance on medication and enhanced patient outcomes, thereby prompting its adoption by healthcare providers and patients alike. Moreover, technological advancements in medical devices have played a significant role in driving market growth. Renal denervation procedures now incorporate innovative catheter systems equipped with either radiofrequency or ultrasound energy for the selective ablation of renal nerves. These technological enhancements have heightened the precision and safety of the procedure, further stimulating its adoption. However, challenges confront the renal denervation market. A prominent obstacle is the absence of long-term clinical data confirming the sustained efficacy and safety of the procedure. While initial studies have shown promising results, additional evidence is required to establish renal denervation as a standard treatment option for hypertension.
Top-down and bottom-up approaches were used to estimate and validate the size of the global renal denervation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report
Global Renal Denervation Market is segmented on the basis of type, technology, and region. By type, the market is segmented into catheters, RF generators, and nerve modifying agents. By technology, the market is segmented into radiofrequency, ultrasound, and micro-infusion. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers:
Technological Advancements
The growth of the market is being propelled by developments in renal denervation technologies, which encompass refined catheter designs, more efficient energy delivery systems, and novel agents for modifying nerves. These innovations significantly improve the procedure's accuracy, safety, and overall effectiveness.
Growing Awareness and Acceptance
The growth of the market is being propelled by a rising awareness of the advantages of renal denervation among both patients and healthcare professionals. This procedure provides benefits that include a decreased need for medication, enhanced management of blood pressure, and the potential for long-term positive outcomes.
Restraints:
Limited Awareness and Adoption in Emerging Markets
Limited awareness and comprehension of renal denervation as a hypertension treatment option may exist in certain developing markets. This deficiency in knowledge, when combined with inadequate healthcare infrastructure, can act as hindrances to market expansion in these areas.
Procedural Complexity and Learning Curve
Renal denervation is a procedure characterized by its technical intricacy, demanding specialized training and proficiency. The intricacies of the procedure and the time it takes to become proficient in it may restrict its widespread utilization, particularly among healthcare providers who are less experienced in this field.
Market Trends:
Transition to Outpatient Renal Denervation: There is an emerging tendency to conduct renal denervation procedures in outpatient or ambulatory settings as opposed to traditional hospital environments. This transition is motivated by factors such as cost-efficiency, patient convenience, and a reduction in the need for hospitalization. Shifting renal denervation to ambulatory settings can expand patient accessibility and promote market growth.
Patient-Focused Strategy: Healthcare providers and entities within the renal denervation sector are increasingly embracing a patient-centric strategy. The emphasis is on delivering customized care, enhancing patient outcomes, and elevating the patient experience throughout the entire renal denervation process. This trend corresponds with the broader movement towards value-based healthcare.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Renal Denervation Market by Type
- Market Overview
- Catheters
- RF generators
- and nerve modifying agents
- Global Renal Denervation Market by Technology
- Market Overview
- Radiofrequency
- ultrasound
- and micro-infusion
- Global Renal Denervation Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Medtronic - Ireland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ReCor Medical - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ablative Solutions - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mercator MedSystems - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- St. Jude Medical (Abbott Laboratories) - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CardioSonic - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Symple Surgical - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Soundbite Medical Solutions - Canada
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vessix Vascular (acquired by Boston Scientific) - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Renal Dynamics (acquired by Boston Scientific) - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kona Medical - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ablacon - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardiosonic Ltd. - Israel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EndoCross Ltd. - Israel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Caldus Medical - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OxSonics - United Kingdom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nexeon MedSystems - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
